Status:
RECRUITING
A Study Assessing the Effects of Acupuncture in Parkinson's Disease Patients With Chronic Appendicitis
Lead Sponsor:
The First Affiliated Hospital of University of Science and Technology of China
Conditions:
Parkinson's Disease
Chronic Appendicitis
Eligibility:
All Genders
40-70 years
Phase:
NA
Brief Summary
The incidence of PD is high, and when the disease is serious to a certain extent, the effect of drugs to control symptoms decreases, resulting in a significant reduction in the quality of life of pati...
Eligibility Criteria
Inclusion Criteria:
- Patients presenting with bradykinesia, combined with resting tremor and/or myotonia.
- Appendix CT suggested chronic appendicitis evaluated by two experienced experts.
- All subjects and their guardians give informed consent to the content of this study and sign informed consent.
- Normal coagulation function.
- If the patient had taken oral anti-PD drugs, it had been stable for at least 2 weeks at enrollment.
Exclusion Criteria:
- Treatment with dopamine blockers or dopamine depleters in doses and time courses consistent with drug-induced parkinsonism.
- Neuroimaging examination of presynaptic dopaminergic system function was normal.
- Patients who had suffered severe brain trauma or underwent complex craniotomy within 5 years prior to enrollment.
- Cognitive disorders that are not on the Parkinson's spectrum, such as Alzheimer's disease, frontotemporal dementia, and Niemann-Pick disease, have been diagnosed.
- People diagnosed with severe neuropsychiatric disorders (epilepsy, bipolar disorder, major depressive episode, etc.) according to DSM-V.
- Complicated with serious systemic diseases, disorders of consciousness, stroke, serious coronary heart disease, diabetes, liver and kidney diseases, and serious visual and hearing disorders.
- Patients with severe organic or functional dysphagia;Those who were deemed by the researcher to be unable to complete the visit and auxiliary examination as required by the study protocol.
Key Trial Info
Start Date :
March 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2026
Estimated Enrollment :
84 Patients enrolled
Trial Details
Trial ID
NCT06304285
Start Date
March 1 2024
End Date
December 31 2026
Last Update
March 12 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The First Affiliated Hospital of University of Science and Technology of China
Hefei, Anhui, China, 230001